标题 |
专利、报告等 A Phase 2 Open-Label Study in Infants With REspiratory Syncytial VIRus Lower RespirAtory Tract Infection, Followed by a DoubLe-blind, Placebo controlled Part, to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Effect of RV521 (REVIRAL 1)
一项针对呼吸道合胞病毒下呼吸道感染婴儿的2期开放标签研究,随后进行双盲、安慰剂对照部分,以评估RV521(REVIRAL 1)的安全性、耐受性、药代动力学和抗病毒作用
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |